港股收评:恒指震荡收涨0.34% 药品股表现抢眼 中生制药飙升近9%
格隆汇8月29日丨今日港股市场低开后震荡上行,主要股指小幅收涨。恒指尾盘拉升全日呈探底回升之势。截至收盘,恒指涨0.34%,报25703.5点。国指涨0.12%,报9992.64点。主板全日成交788.67亿港元,港股通净流入23.77亿港元。从板块表现看,内地医药股继续强势领涨,体育用品股、水务股、奢侈品股现普涨行情,奶制品股跌幅最大,夜店股、内房股、百货业股、重型机械股普跌。个股方面,中生制药涨近9%为最佳恒指成份股;石药集团涨近4%;中电控股、中国旺旺涨逾3%;舜宇、友邦、恒安国际等纷纷上涨;蒙牛乳业绩后跌超5%领跌蓝筹;港铁跌逾1%;中银香港、长实集团、九龙仓置业皆走弱;港股通标的股威高股份、金斯瑞生物科技涨逾7%;中国信达涨6%;青岛啤酒、中国华融涨逾5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.